Cargando…
Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer
Development of effective tumor cell–targeted nanodrug formulations has been quite challenging, as many nanocarriers and targeting moieties exhibit nonspecific binding to cellular, extracellular, and intravascular components. We have developed a therapeutic nanoparticle formulation approach that bala...
Autores principales: | Dancy, Jimena G., Wadajkar, Aniket S., Connolly, Nina P., Galisteo, Rebeca, Ames, Heather M., Peng, Sen, Tran, Nhan L., Goloubeva, Olga G., Woodworth, Graeme F., Winkles, Jeffrey A., Kim, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962043/ https://www.ncbi.nlm.nih.gov/pubmed/31998833 http://dx.doi.org/10.1126/sciadv.aax3931 |
Ejemplares similares
-
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
por: Hersh, David S., et al.
Publicado: (2016) -
Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer
por: Connolly, Nina P., et al.
Publicado: (2017) -
TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
por: Cheng, Emily, et al.
Publicado: (2013) -
TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion
por: Armstrong, Cheryl L., et al.
Publicado: (2016) -
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
por: Harder, Bryan G., et al.
Publicado: (2018)